InsiderTrades

Form 4 for KNSA Kiniksa Pharmaceuticals International, plc

Accepted 2025-11-14 00:00:00 ET · period of report 2025-11-12 · accession 0001532218-25-000007 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MI 2025-11-14 2025-11-12+ KNSA Patel Sanj K COB, CEO, Dir G - Gift $0.00 +111.8K 60.0K New $0
2025-11-14 2025-11-12 KNSA Patel Sanj K COB, CEO, Dir G - Gift $0.00 -111.8K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Ordinary Share 2025-11-12 G A 111,794 $0.00 111,794 I Held by The Anglia 2013 Revocable Trust — —
2 Common Class A Ordinary Share 2025-11-12 G D 111,794 $0.00 0 D — —
3 Common Class A Ordinary Share 2025-11-13 G D 60,000 $0.00 51,794 I Held by The Anglia 2013 Revocable Trust — —
4 Common Class A Ordinary Share 2025-11-13 G A 60,000 $0.00 60,000 I Held by The Patel Family Irrevocable Trust of 2025 — —